Advertisement
Canada markets open in 26 minutes
  • S&P/TSX

    22,824.67
    +45.10 (+0.20%)
     
  • S&P 500

    5,436.44
    -27.10 (-0.50%)
     
  • DOW

    40,743.33
    +203.40 (+0.50%)
     
  • CAD/USD

    0.7239
    +0.0017 (+0.24%)
     
  • CRUDE OIL

    77.52
    +2.79 (+3.73%)
     
  • Bitcoin CAD

    91,347.60
    -774.73 (-0.84%)
     
  • CMC Crypto 200

    1,354.30
    +4.18 (+0.31%)
     
  • GOLD FUTURES

    2,464.90
    +13.00 (+0.53%)
     
  • RUSSELL 2000

    2,243.14
    +7.81 (+0.35%)
     
  • 10-Yr Bond

    4.1240
    -0.0190 (-0.46%)
     
  • NASDAQ futures

    19,349.75
    +413.50 (+2.18%)
     
  • VOLATILITY

    16.47
    -1.22 (-6.90%)
     
  • FTSE

    8,376.99
    +102.58 (+1.24%)
     
  • NIKKEI 225

    39,101.82
    +575.87 (+1.49%)
     
  • CAD/EUR

    0.6676
    +0.0001 (+0.01%)
     

This CVS Health Insider Reduced Their Stake By 85%

Looking at CVS Health Corporation's (NYSE:CVS ) insider transactions over the last year, we can see that insiders were net sellers. That is, there were more number of shares sold by insiders than there were purchased.

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

See our latest analysis for CVS Health

The Last 12 Months Of Insider Transactions At CVS Health

The Senior VP, James Clark, made the biggest insider sale in the last 12 months. That single transaction was for US$1.9m worth of shares at a price of US$74.94 each. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$65.84. So it is hard to draw any strong conclusion from it. James Clark was the only individual insider to sell shares in the last twelve months.

ADVERTISEMENT

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insiders At CVS Health Have Sold Stock Recently

Over the last three months, we've seen significant insider selling at CVS Health. Specifically, Senior VP James Clark ditched US$1.9m worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.

Does CVS Health Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. CVS Health insiders own 0.2% of the company, currently worth about US$207m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At CVS Health Tell Us?

An insider sold CVS Health shares recently, but they didn't buy any. Despite some insider buying, the longer term picture doesn't make us feel much more positive. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Case in point: We've spotted 5 warning signs for CVS Health you should be aware of.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.